Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production.

Siednienko J, Gajanayake T, Fitzgerald KA, Moynagh P, Miggin SM.

J Immunol. 2011 Feb 15;186(4):2514-22. doi: 10.4049/jimmunol.1003093. Epub 2011 Jan 19.

2.

TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.

Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM.

Eur J Immunol. 2010 Nov;40(11):3150-60. doi: 10.1002/eji.201040547. Epub 2010 Oct 19.

3.

Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.

Youn HS, Lim HJ, Choi YJ, Lee JY, Lee MY, Ryu JH.

Int Immunopharmacol. 2008 Mar;8(3):495-501. doi: 10.1016/j.intimp.2007.12.008. Epub 2008 Jan 14.

PMID:
18279804
4.

Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.

Dong LW, Kong XN, Yan HX, Yu LX, Chen L, Yang W, Liu Q, Huang DD, Wu MC, Wang HY.

Mol Immunol. 2008 Jun;45(11):3025-35. doi: 10.1016/j.molimm.2008.03.012. Epub 2008 May 8.

PMID:
18471880
5.

Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.

Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G.

J Immunol. 2003 Apr 1;170(7):3565-71.

6.

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

Sirén J, Pirhonen J, Julkunen I, Matikainen S.

J Immunol. 2005 Feb 15;174(4):1932-7.

7.

Differential effects of CpG DNA on IFN-beta induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages.

Schroder K, Spille M, Pilz A, Lattin J, Bode KA, Irvine KM, Burrows AD, Ravasi T, Weighardt H, Stacey KJ, Decker T, Hume DA, Dalpke AH, Sweet MJ.

J Immunol. 2007 Sep 15;179(6):3495-503.

8.

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S.

J Immunol. 2002 Dec 15;169(12):6668-72.

10.

Viral activation of macrophages through TLR-dependent and -independent pathways.

Malmgaard L, Melchjorsen J, Bowie AG, Mogensen SC, Paludan SR.

J Immunol. 2004 Dec 1;173(11):6890-8.

11.

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S.

Science. 2003 Aug 1;301(5633):640-3. Epub 2003 Jul 10.

12.

Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.

Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, Takayanagi H, Ohba Y, Taniguchi T, Honda K.

Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15136-41. Epub 2006 Oct 3.

13.

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T.

Nat Immunol. 2003 Feb;4(2):161-7. Epub 2003 Jan 21.

PMID:
12539043
14.

TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker.

Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH, Suk K.

J Immunol. 2005 May 15;174(10):6467-76.

15.

Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.

Johnson J, Albarani V, Nguyen M, Goldman M, Willems F, Aksoy E.

J Biol Chem. 2007 May 18;282(20):15022-32. Epub 2007 Feb 12.

16.

SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.

Huang J, Liu T, Xu LG, Chen D, Zhai Z, Shu HB.

EMBO J. 2005 Dec 7;24(23):4018-28. Epub 2005 Nov 10.

17.

Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.

Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM.

Glia. 2011 Feb;59(2):242-55. doi: 10.1002/glia.21094.

PMID:
21125645
18.

TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.

Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T.

J Biol Chem. 2003 Dec 12;278(50):49751-62. Epub 2003 Sep 30.

19.

TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.

Park SJ, Lee AN, Youn HS.

Arch Pharm Res. 2010 Jun;33(6):939-45. doi: 10.1007/s12272-010-0618-2. Epub 2010 Jul 6.

PMID:
20607500
20.

Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists.

Youn HS, Ahn SI, Lee BY.

Int Immunopharmacol. 2009 Jan;9(1):108-12. doi: 10.1016/j.intimp.2008.10.012. Epub 2008 Nov 8.

PMID:
19000789
Items per page

Supplemental Content

Write to the Help Desk